Embla Medical hf (FRA:5IQ) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5IQ Embla Medical hf FRA:5IQ
71 GF Score
Price €3.51
GF Value €4.62
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Embla Medical hf FFO per Share?

FFO per Share only applies to REITs.

FRA:5IQ
71GF Score
Embla Medical hf FRA:5IQ
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Embla Medical hf (FRA:5IQ) Overvalued in 2026?

Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued. The current stock price of €3.51 is trading 24.1% below its estimated GF Value™ of €4.62. GuruFocus considers Embla Medical hf to be Modestly Undervalued.

Key valuation signals for FRA:5IQ:

  • FFO per Share:
  • GF Value™: €4.62 vs. price of €3.51 (24.1% below fair value)
  • GF Score™: 71/100 with 2 warning signs

No single metric tells the full story. See the FRA:5IQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Embla Medical hf Business Description

Other Exchanges 0FIW:UKEMBLA:Denmark
Address Grjothals 5, Reykjavik, ISL
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
71GF Score

Get the complete analysis for FRA:5IQ

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.51
Price
€4.62
GF Value